IBI Blog On Retirement Secrets: Mentorship Will Change Your Life

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Integrated biosci research, consultant

Contributor Since 2013

Founded by Dr. Harvey Tran MD, MS, CNPR, (in collaboration with other PhDs), Integrated BioSci Investing LLC (“IBI) is a growing community of experts and everyday investors who help one another to invest better.

We bring to you a NEW investment philosophy called “Integrated BioSci Investing.” It's a distillation of value/growth investing wisdom from gurus such as Warren Buffett, Buffet's mentors (Ben Graham and Phil Fischer), and Sir John Templeton that are adapted specifically for biotech stocks.

IBI's analytical research is powered by the integration of (medical, scientific, and market) expertise to deliver unprecedented accuracy in clinical trial forecasting that, in and of itself, is one of the requisites to finding alpha bioscience investment.

Ultimately, our tireless due diligence and the wisdom of IBI members translate into strong returns for you. To name a couple of winners, Crispr Therapeutics (CRSP), CryoPort (CYRX), and Guardant Health (GH), correspondingly delivered 679.1%, 778.3%, and +435.9% for our subscribers."

As an IBI member, you’ll enjoy the following EXCLUSIVE benefits: daily real-time research articles that are comprehensive and more in-depth than free research articles; access to the chat room with many experts and everyday investors for you to ask your questions live about your favorite stocks (you’re expected to get an answer no later than 24 hours); ability to view our high performing portfolios and their pertinent updates; consulting on strategies to help you set up your own portfolios; Our best ideas and their updates via a research article or chat; potential to have research featured on your favorite companies; ability to reach Dr. Tran via phone call or Skype as you wish.

CLICK the orange FOLLOW button to receive the FREE real-time alerts on our articles and blogs.

CONNECT with Dr. Tran through his LinkedTree https://linktr.ee/DrHarveyTran

READ more on www.drtranbiosci.com (and make sure to register for our mailing list).

LEARN about Dr. Tran’s background in an in-depth article by following this link. http://www.drtranbiosci.com/p/dr-tran.html

"Stellar therapeutics for patients. Differentiated intelligence for investors. Premium valuations for firms."

You might think that you need to be a genius to enjoy successful investing.

But that's conventional wisdom. 

And, conventional wisdom is almost always wrong!

What you need is street smart to bank huge profits.

That way, you can enjoy luxurious items, like a Rolls Royce, a Hermes bag, or a new yacht.


You might be asking: Dr. Tran, what exactly is that street smart you're talking about?

Well, my friend, street smart entails many things.

One thing is to leverage other's expertise.

Another is to seek mentorship.

It's not possible for you to know everything.

This is true in biotech investing as well as in life.

So why don't you harness your mentor wisdom to succeed?

Your mentor will have countless years of experience under his or her belt.

And, a great mentor will share with you his wisdom.

As a mentor, I've shared invaluable insight with my mentees for years.

For instance, I hammered the message that "certain rallying stock can rally further." 

This is especially true for Philip Fisher's growth biotech.

As you can see, Mr. Fisher is Warren Buffett's mentor.

Even Mr. Buffett has his mentor.

And Mr. Buffett is mentoring Bill Gates.

What about you?

Don't you think you deserve a chance for mentorship?

It doesn't matter your age.

And, Bill Gates found Buffett later in his life.

The Colonel started KFC in his mid-60s.

You can be 80 and still seeking a mentor.

Having a mentor will change your life for the better.

Coming back to what I said earlier: certain rallying stock will rally further.

That is especially true for Alpine Immune Sciences (ALPN).

If you don't know the story on ALPN, make sure you read the prior blog

Back in June, ALPN inked a partnership with AbbVie (ABBV).

As such, the stock shot up over 80% in one day.

After trading sideways for weeks, my intuition tells me it'll rally higher.

As it turned out, ALPN has been trading aggressively higher in the past months. 

You can see that ALPN is a stock whose time has come.

And, I believe it will reach a new high going into 2021. 

Check out the IBI-research on ALPN that I just featured inside our community. You don't want to miss out on that one.

In that article, I laid out specific details on catalysts that can take ALPN to a new high.

ALPN is special!

That's why I recently featured it in my Top 3 picks for 2021 that I shared with all my readers.

If you want to earn more for 2021, catch rallying stocks before they move, be all that you can be, check out IBI, and leverage our mentorship.

At IBI: Everyone is getting smarter. Everyone is respected. You don't feel like a fool. And you’re a part of something bigger than yourself.

Inside IBI, we stay ahead of the market!

I'm so confident in the value of my service that I'm giving you a 2-week FREE trial, money-back guarantee.


Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Additional disclosure: As a medical doctor/market expert, I'm not a registered investment advisor. Despite that I strive to provide the most accurate information, I neither guarantee the accuracy nor timeliness. Past performance does NOT guarantee future results. I reserve the right to make any investment decision for myself and my affiliates pertaining to any security without notification except where it is required by law. I'm also NOT responsible for the action of my affiliates. The thesis that I presented may change anytime due to the changing nature of information itself. Investing in stocks and options can result in a loss of capital. The information presented should NOT be construed as recommendations to buy or sell any form of security. My articles are best utilized as educational and informational materials to assist investors in your own due diligence process. That said, you are expected to perform your own due diligence and take responsibility for your action. You should also consult with your own financial advisor for specific guidance, as financial circumstances are individualized.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.